Clinical Trial Update: Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for an antidepressant targeting negative symptoms in schizophrenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Imperial College London | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2024-03-28